Quality assessment of evidence-based clinical practice guidelines for the management of pregnant women with sickle cell disease using the AGREE II instrument: a systematic review

BMC Pregnancy and Childbirth

Yasser S. Amer¹  Musa F. Alzahrani²  Amer M. Altaki³  Yasser Sabr⁴  Ahmed El-Malky⁵  Osamah T. Khojah⁶  Ghada M. ElGohary⁷ 

[1]Clinical Practice Guidelines Unit, Quality Management Department, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia

[2]Department of Pediatrics, King Khalid University Hospital, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia

[3]Research Chair for Evidence-Based Health Care and Knowledge Translation, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia

[4]Alexandria Center for Evidence-Based Clinical Practice Guidelines, Alexandria University, Alexandria, Egypt

[5]Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia

[6]Department of Obstetrics and Gynecology, College of Medicine, King Saud University, Riyadh, Saudi Arabia

[7]Department of Obstetrics and Gynecology, College of Medicine, King Saud University, Riyadh, Saudi Arabia

[8]Prince Sattam Bin Abdul Aziz Research Chair for Epidemiology and Public Health, College of Medicine, King Saud University, Riyadh, Saudi Arabia

[9]Morbidity and Mortality Unit, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia

[10]Public Health and Community Medicine Department, Theodor Bilharz Research Institute (TBRI), Academy of Scientific Research, Cairo, Egypt

[11]Pathology Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia

[12]University Oncology Center, King Saud University Medical City, College of Medicine, King Saud University, Riyadh, Saudi Arabia

[13]Internal Medicine and Clinical Hematology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

关键词: Sickle cell disease;    pregnancy;    practice guidelines;    AGREE II instrument;    quality assessment;   

DOI  :  10.1186/s12884-020-03241-y

来源: Springer

【 摘 要 】

BackgroundThe management of pregnant women with sickle cell disease (SCD) poses a major challenge for maternal healthcare services owing to the potential for complications associated with morbidity and mortality. Trustworthy evidence-based clinical practice guidelines (CPGs) have a major impact on the positive outcomes of appropriate healthcare. The objective of this study was to critically appraise the quality of recent CPGs for SCD in pregnant women.MethodsClinical questions were identified and the relevant CPG and bibliographic databases were searched and screened for eligible CPGs. Each CPG was appraised by four independent appraisers using the AGREE II Instrument. Inter-rater analysis was conducted.ResultsFour eligible CPGs were appraised: American College of Obstetricians and Gynecologists (ACOG), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Health and Care Excellence (NICE), and Royal College of Obstetricians and Gynaecologists (RCOG). Among them, the overall assessments of three CPGs (NICE, RCOG, NHLBI) scored greater than 70%; these findings were consistent with the high scores in the six domains of AGREE II, including:[1] scope and purpose,[2] stakeholder involvement,[3] rigor of development,[4] clarity of presentation,[5] applicability, and [6] editorial independence domains. Domain [3] scored (90%, 73%, 71%), domain [5] (90%, 46%, 47%), and domain [6] (71%, 77%, 52%) for NICE, RCOG, and NHLBI, respectively. Overall, the clinical recommendations were not significantly different between the included CPGs.ConclusionsThree evidence-based CPGs presented superior methodological quality. NICE demonstrated the highest quality followed by RCOG and NHLBI and all three CPGs were recommended for use in practice.

【 授权许可】

CC BY